Toggle navigation
Home
Search
Services
Blog
Contact
About
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V.
Immunogen, Inc., Cambridge, MA, United States
Search 16 grants from Ravi Chari
Search grants from Immunogen, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Feed Safety and BSE/Ruminant Feed Ban Support Project (U18)
Safe Patient Handling Legislation and MSDs in California Healthcare Workers
Secreted Proteins as Breast Cancer Prevention Markers
Genetic Regulation in Drosophila: Dosage Compensation
Molecular Mechanisms of Neurosecretion
Recently added grants:
Direct chemical control of the hematopoietic master transcription factor PU.1
Statistical and high-throughput models of enhancer function and evolution
Microbiota-Dependent Control of Clostridium Difficile: the Role of Acetate and IL-22 Binding Protein
Cognitive training to reduce incidence of cognitive impairment in older adults
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA056209-02A3
Application #
2008020
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Project Start
1992-07-01
Project End
1999-03-31
Budget Start
1997-07-11
Budget End
1998-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Immunogen, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 1998
R44 CA
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V. / Immunogen, Inc.
NIH 1997
R44 CA
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V. / Immunogen, Inc.
Publications
Xie, Hongsheng; Audette, Charlene; Hoffee, Mary et al.
(2004)
Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice.
J Pharmacol Exp Ther 308:1073-82
Comments
Be the first to comment on this grant